编辑丨于靖
9月13日,Akero Therapeutics宣布旗下药物Efruxifermin(EFX,曾用名AKR-001)在IIb期HARMONY研究中,可改善肝硬化前期非酒精性脂肪性肝炎(NASH)患者的肝纤维化并防止疾病恶化,Efruxifermin 28mg和50mg剂量组均达到了改善肝脏纤维化的主要终点以及多个次要终点...查看全文
chuminhua2021-08-26 14:55
8月25日,Lipocine公司宣布,其在研疗法LPCN 1144,在治疗非酒精性脂肪性肝炎(NASH)男性患者的2期概念验证临床试验LiFT中获得积极结果。LPCN 1144是一种口服的睾酮前药。NASH是全球肝衰竭和肝移植的主要原因,是非酒精性脂肪性肝病(NAFLD)的一种更晚期状态,可进展为肝硬化,最终发展为肝癌。...查看全文
SnowBall2020Q42021-02-05 22:17
$Lipocine(LPCN)$ 号称口服睾丸酮对于老年男性新冠患者有帮助,但是炒作第一波已经过了。口服治疗方案具体咋样还没有仔细研究。查看全文
$LIPOCINE INC NEW(LPCN)$ 8-K - Current report Filed: 2016-09-26 AccNo: 0001144204-16-125165 Size: 33 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$LIPOCINE INC NEW(LPCN)$ 8-K - Current report Filed: 2016-08-10 AccNo: 0001144204-16-117897 Size: 3 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$LIPOCINE INC NEW(LPCN)$ 8-K - Current report Filed: 2016-08-09 AccNo: 0001144204-16-117435 Size: 109 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$LIPOCINE INC NEW(LPCN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-08-09 AccNo: 0001144204-16-117433 Size: 3 MB 网页链接
$LIPOCINE INC NEW(LPCN)$ CT ORDER - Confidential treatment order Filed: 2016-07-26 AccNo: 9999999997-16-024625 Size: 13 KB 网页链接
$LIPOCINE INC NEW(LPCN)$ 8-K - Current report Filed: 2016-07-18 AccNo: 0001144204-16-113390 Size: 23 KBItem 2.05: Cost Associated with Exit or Disposal Activities 网页链接
$LIPOCINE INC NEW(LPCN)$ 8-K - Current report Filed: 2016-06-29 AccNo: 0001144204-16-110368 Size: 34 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$LIPOCINE INC NEW(LPCN)$ 8-K - Current report Filed: 2016-06-27 AccNo: 0001144204-16-109890 Size: 37 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$LIPOCINE INC NEW(LPCN)$ 8-K - Current report Filed: 2016-06-15 AccNo: 0001144204-16-108268 Size: 33 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$LIPOCINE INC NEW(LPCN)$ 8-K - Current report Filed: 2016-05-27 AccNo: 0001144204-16-105499 Size: 301 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接